Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F8E5W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,307
Award facts
- Contract value 100% obligated
- $13,306.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,306.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections on January 16, 2026, with performance completion scheduled for January 20, 2026. This non-set-aside contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, operating as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. The delivery of Zepbound, a diabetes medication, aligns with the contractor's extensive portfolio of pharmaceutical products covering multiple therapeutic domains including endocrinology, oncology, and specialty care medications. This delivery order exemplifies the routine execution of the DLA's pharmaceutical supply chain operations, leveraging Cencora's established infrastructure and competitive positioning to fulfill ongoing federal medical commodity requirements.
Quick answers
Who was awarded contract SPE2DR26F8E5W?
SPE2DR26F8E5W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F8E5W worth?
The government has obligated $13,307 on SPE2DR26F8E5W.
Is contract SPE2DR26F8E5W an order under another contract?
Yes. SPE2DR26F8E5W is a delivery order under SPE2DR25D3202, an indefinite delivery contract.
Was contract SPE2DR26F8E5W competed?
The extent of competition for SPE2DR26F8E5W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award